Tumor development, or tumorigenesis, broadly describes the process by which normal cells gain malignant properties. Tumor development includes growth functions like cellular differentiation, proliferation, and metastasis.
-
Date: November 16, 2022 Time: 2:00pm (AEST) Date: November 17, 2022 7:00pm (PST), 10:00pm (EST), 4:00am (CET) The growth in FDA-approved cell and gene therapy products for the treatment of d...
Date: November 16, 2022 Time: 9:00am (PST), 12:00pm (EST), 6:00pm (CET) No more estimating. No more ranges. No more uncertainty. While PDX tumor models are crucial for gaining predictive ins...
Date: October 13, 2022 Time: 10:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Most known immune checkpoints exert their effects upon protein-protein interactions, such as the PD1 checkpoint on CD...
My laboratory uses tools from pharmacology, genomics, and cell signaling to study two key aspects of cancer biology. First, we seek to understand how oncogenic signals, altered metabolic sta...
Date: October 26, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Immunotherapy has transformed the treatment of metastatic and recurrent solid tumors. Advances in technology in the pa...
Date: October 13, 2022 Time: 11:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) Single-cell atlases mapping immune cells provide hints on how immune cells mature, attenuate, and disseminate through...
Learning Objectives 1. Identify 3 obstacles that inhibit the immune cell response to cancer. 2. List 3 aspects of T cells antitumor function that can be improved with costimulatory signals....
The majority of disease-associated genetic variants are thought to have regulatory effects, including disruption of transcription factor (TF) binding and alteration of downstream gene expres...
Date: September 22, 2022 Time: 8:00am (PDT), 11:00pm (EDT), 5:00pm (CEST) Liquid biopsies are used to identify and track genetic mutationsin cancer patinets, enabling researchers to detect c...
In the United States, prostate cancer (PCa) is the second-leading cause of cancer death in men. Multiple observations indicate the link between prostate carcinogenesis, stress of endoplasmi...
Date: August 24, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Next Generation Sequencing (NGS) has evolved rapidly since the first sequencing platforms were commercially released ne...
Date: August 18, 2022 Time: 3pm AEST | 1pm SGT | 2pm JP/KR Kirsten rat sarcoma viral oncogene homologue (KRAS) is the most frequently mutated oncogene, present in approximately 25% of tumors...
Date: June 29, 2022 Time: 12:00pm (PST), 2:00pm (EST), 8:00pm (CEST) The burden of antimicrobial resistance (AMR) has been acknowledged worldwide by leading health institutes. Besides the ne...
Date: June 02, 2022 Time: 8:30am (PST), 10:30am (CST), 11:30am (EST) Cardiac biomarkers like high-sensitivity Troponin I might play a major role in the prevention of cardiovascular diseases....
Date: May 31, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) Introducing Nanostring’s latest spatial platform, CosMx Spatial Molecular Imager (SMI). Offering high-plex, multiomi...
Date: May 25, 2022 Time: 10:00am (PDT), 1:00pm (EDT), 7:00pm (CEST) Programmable RNA base editors are excellent tools to modify RNA transcripts at precise locations or designated hotspots. P...
Date: May 24, 2022 Time: 11:00am (PDT), 2:00pm (EDT), 7:00pm (CEST) NGS tumor profiling has become the mainstay of modern cancer therapy. Several NCCN-guided and FDA-approved therapies are c...
Date: May 19, 2022 Time: 8:00am (PDT), 11:00pm (EDT), 5:00pm (CEST) Mass spectrometry (MS)-based proteomic technologies are increasingly applied in a clinical context for disease classific...
Invitrogen ProcartaPlex and QuantiGene Plex assays offer the unique ability of a multi-omics high-throughput approach by utilizing the Luminex platform. Genomic and proteomic workflows can b...